The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.
Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. Our members supply 90 per cent of all medicines used by the NHS, and are researching and developing over two-thirds of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases.
The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry, for statutory consultation requirements including the pricing scheme for medicines in the UK.
Our departments span a range of key areas: Commercial, Communications, Legal, Membership Services, NHS Partnerships, and Research, Medical and Innovation.
The ABPI Commercial function has three aims: pricing and value, partnership and uptake and distribution and supply. Key areas are medicines pricing and reimbursement, health technology appraisals and assessment of cost effectiveness, delivering quality outcomes, working with the NHS on Quality, Innovation, Productivity & Prevention (QIPP), distribution and supply of medicines, as well as patients’ access to medicines.
The Commercial Team works with industry, the Government, NICE, the NHS and other stakeholders to ensure that medicines’ true value is understood and assessed appropriately and that patients and the NHS can access the medicines they need when they need them.
The Commercial Team drives the implementation of initiatives to ensure that industry is working productively and jointly with the NHS to ensure improved patient outcomes in a wide range of disease areas. The team also leads on the Pharmaceutical Price Regulation Scheme (PPRS).
To find out more about the work of the Commercial Team, visit the
Value and access and
The Communications Team covers many disciplines, from Government liaison, media interaction and stakeholder engagement through to internal/employee communications and – equally importantly – engaging with our member companies and sharing all our insights and skills.
The Communications Team works very closely with all other departments to help spread the word about the diverse range of activities we undertake. They do this through supporting the Research, Medical and Innovation department in its work to improve the UK environment for the research, development and manufacturing of medicines, and the Commercial Team in its work around ensuring that medicines’ true value is assessed and understood and that patients can receive the right medicine at the right time.
Our Policy and Public Affairs Team seeks to ensure that the industry’s position on relevant policy issues is communicated to Government and other stakeholders in the most effective manner. We provide advice and analysis for the ABPI and its member companies on significant policy and political developments. The team produces information for members, Government and Parliament, including policy briefing papers and responses to consultations.
The ABPI also provides secretariat support for the All Party Parliamentary Group (APPG) on the Pharmaceutical Industry and the APPG Life Sciences.
Our Press Office Team is always on hand to provide journalists with information on the diverse range of subjects that are relevant to the pharmaceutical industry. Our role is to ensure that any type of media is able to have access to the industry perspective and opinion.
We provide a 24/7 service to the media and are always on hand to provide our member companies with advice and support on media matters, whenever they need it.
ABPI Media Centre carries all the news releases issued by the ABPI, as well as biographies and key facts on a range of topical industry subjects.
Our Legal Team provides direct support to help scope and deliver the policies and activities which are pursued by the Association. The Legal Department does not provide advice to individual member companies, but does look at legal aspects of the ABPI's programme of activities. The issues vary from day to day, but will typically include:
As a membership organisation, we work with our member companies and the expertise of the specialists they employ to develop and present our points of view to UK and European governments, the public and other stakeholders.
Our Membership Services Team works to ensure that our members stay informed about industry developments through regular industry monitoring updates and events. We also offer members the opportunity to join a range of expert networks or working groups focused on their interests and expertise.
To find out more about the team's work, visit the
Membership area and our
Our NHS Partnership Team works to build relationships with the NHS at a regional level with the aim of improving patient health.
In practice, this means working in partnership to:
The NHS Partnership team comprises of four Regional Partnership Managers covering the NHS regions: north, midlands & east, London and south. Each Regional Partnership Manager is focused on improving the environment for access and uptake of innovative medicines by facilitating partnership working between member companies and NHS stakeholders.
The NHS Partnership team is also responsible for the oversight and strategic alignment of the ABPI therapy groups through the Therapy Group Manager and Executive.
The ABPI Research, Medical and Innovation Team works to improve the UK environment for the research, development and manufacturing of medicines. The team does this by promoting industry-academic-NHS collaboration and ensuring the UK is a leader in stratified medicines, early stage clinical studies and in the development of data on how medicines provide value to patients and the NHS (Real World Data). In addition, the team is involved in:
Optimising the UK regulatory environment and medicine safety monitoring
Administration and maintenance of the ABPI exam for Medical Representatives
To find out more about their work, visit the
Research, medical and innovation section.